Nicholas Raccagni: Heparin for VTE Prevention After Traumatic Brain Injury
Nicholas Raccagni, Biomedical Research Trainee at Virgilio Program, Neurosurgery Internship at Fondazione IRCCS Istituto Neurologico Carlo Besta (Milan, Italy), shared a post on LinkedIn about a recent article he and his colleges co-authored, published in Neurosurgery, adding:
“Venous thromboembolism prophylaxis after traumatic brain injury sits at the intersection of thrombosis prevention and hemorrhagic risk.
In our recent article in Neurosurgery, we compared low-molecular-weight heparin and unfractionated heparin in adults with TBI, synthesizing the available direct comparative evidence and examining the consistency of observed associations across TBI phenotypes.
Our findings point to a clinically relevant signal, but one that remains difficult to disentangle from treatment selection and residual confounding present within the entirely retrospective evidence base.
Prospective studies are needed to determine whether this signal is causal and how it should inform thromboprophylaxis in TBI.
I am especially grateful to Leonardo Di Cosmo and Ismail Zaed for their close collaboration throughout this project, and to all my co-authors for their contributions.”
Title: Low-Molecular-Weight Heparin Versus Unfractionated Heparin for Venous Thromboembolism Prophylaxis in Adult Traumatic Brain Injury: A Systematic Review and Meta-Analysis
Authors: Nicholas Giulio Raccagni, Leonardo Di Cosmo, Marco Dotti, Filippo Emanuele Colella, Sofia Carmelini, Ismail Zaed
Stay updated on all scientific advances with Hemostasis Today.
-
Sep 15, 2026, 09:34Mario D. Caldararo: Are Lines of Zahn Pathognomonic for Antemortem Thrombosis?
-
Sep 15, 2026, 09:24Vishakha K. Kumar: ISTH Is Hiring – Exhibition and Sponsorship Operations Manager
-
Sep 15, 2026, 09:15Mark Mamlouk: The Hidden CSF Leak in Postpartum Headache
-
Sep 15, 2026, 08:59Abdelaziz Fahem: HLH in the GCC – A New Regional Consensus for Diagnosis and Management
-
Sep 15, 2026, 08:13Salih Ehsan: Unraveling the Complex Phenotypes of TDT and NTDT
-
Sep 15, 2026, 07:52Tammuella Chrisentery-Singleton: Honored to Present at AHAD-AP Bangkok
-
Sep 15, 2026, 07:38Aaron Paul Kithcart: Connecting Science and Collaboration in Nagasaki
-
Sep 15, 2026, 02:59Caterina Casari: Curious about How Gene Editing is Revolutionizing Our Field?
-
Sep 15, 2026, 02:53Alejandro González Veliz: Can Lifestyle Changes Actually Reverse Atherosclerosis?